Cross Country Healthcare (CCRN)
(Delayed Data from NSDQ)
$18.72 USD
+0.29 (1.57%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $18.73 +0.01 (0.05%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth D Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
CCRN 18.72 +0.29(1.57%)
Will CCRN be a Portfolio Killer in March?
Zacks Investment Research is releasing its prediction for CCRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CCRN
New Strong Sell Stocks for February 27th
5 Stocks Favored by Brokers Amid the Current Uncertainty
CCRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cross Country (CCRN) Reports Q4 Earnings: What Key Metrics Have to Say
Curious about Cross Country (CCRN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
The Zacks Analyst Blog Highlights Cross Country Healthcare, HireQuest, Heidrick & Struggles, KornFerry and TrueBlue
Other News for CCRN
Analysts Offer Insights on Healthcare Companies: Cross Country Healthcare (CCRN) and Viking Therapeutics (VKTX)
Cross Country Healthcare price target lowered by $2 at Barrington, here's why
Cross Country Healthcare to Attend the Oppenheimer 34th Annual Healthcare Conference
Cross Country Healthcare Issues Non-Binding Regulatory Update
4 Analysts Have This To Say About Cross Country Healthcare